Author guidelines

Aims and scope

The Journal of Breast Imaging (JBI), the official journal of the Society of Breast Imaging, is a peer-reviewed publication that aims to provide high quality, evidence-based content for the global breast imaging medical community. JBI seeks to advance the field of breast imaging, with a particular focus on improving patient care and outcomes. JBI; publishes original research, as well as reviews of important scientific, educational and clinical topics.

Among the topics covered are screening for breast cancer, diagnosis of disease, image-guided breast procedures, and imaging management of patients with breast cancer. The journal reviews emerging and controversial topics by experts to summarize evidence-based research and practice while updating readers on practice management topics. JBI maintains a strong clinical focus with broad appeal with the goal of advancing the field of breast imaging.

How we publish

JBI is a peer-reviewed journal publishing 6 issues per year online.

After copyediting and review of the final proof, papers are published in an issue.

Submitting

JBI is an official publication of Society of Breast Imaging. To publish the Journal, Society of Breast Imaging partners with Oxford University Press (OUP), a not-for-profit publisher and a department of the University of Oxford. Learn more about how publishing with OUP reinvests in the scholarly community on the OUP For Authors page.

After preparing your manuscript according to the guidance in the Preparing your manuscript section, you can submit your work through the Journal’s online submission site. If you have not used our submission site before, you will need to create an account. Additional help and instructions are available on the submission site as you go through the process. Please contact us with any questions about submitting your manuscript

Manuscript format, structure, and style

Article type guide

Manuscript types

Overview

Science of screening

These are brief summary reviews on focused breast cancer screening topics. These manuscripts may be invited by the editor, but unsolicited submissions are equally welcome.

• Please see a representative example of this manuscript type.

Original research

These articles communicate new knowledge gained through original research or meta-analysis. Studies should have a stated hypothesis with appropriate statistical analyses. For human studies, please include institutional review board (IRB) and Health Insurance Portability and Accountability Act (HIPAA) compliance (U.S. studies) information as appropriate at the beginning of the methods section. In addition, please include if informed consent was obtained or waived by the IRB. For a retrospective study an example statement may be “This study was approved by our institutional review board who granted a waiver of consent. The study was compliant with the Health Insurance Portability and Accountability Act (HIPAA).” If the submitted work represents a prospective clinical trial, please include registry information such as from ClinicalTrials. For animal studies, include appropriate ethics approval.

• Please see a representative example of this manuscript type.

Scientific review articles

These are comprehensive focused reviews of the scientific literature written by experts in the field. These should not present new research work or meta-analysis. These manuscripts may be invited by the editor, but unsolicited submissions are equally welcome.  All will undergo peer-review.

• Please see a representative example of this manuscript type.

Educational review articles

These are comprehensive focused summary articles with the purpose of organizing information to educate readers. These will typically be image rich with text to explain teaching points, but do not require the same degree of depth as a Scientific Review article. These manuscripts may be invited by the editor, but unsolicited submissions are equally welcome. These will all undergo peer review. CME will be offered with each of these articles once published.

• Please see a representative example of this manuscript type.

Clinical practice

These are focused summary articles on topics related to the operation and clinical practice of breast imaging. They should not present new data or meta-analysis and do not have the depth of scientific reviews. These manuscripts may be invited by the editor, but unsolicited submissions are equally welcome. These will all undergo peer review.

• Please see a representative example of this manuscript type.

Radiologic–pathologic correlation

The goal of these articles is to facilitate assessment of radiologic-pathologic concordance (and recognition of discordance) after image-guided needle biopsy.  It is expected that one or two radiologists will work closely with a pathologist (no more than 4 authors) to select a minimum of 3 and maximum of 5 cases with paired imaging-pathology images that are high-quality illustrative examples of the entity presented and its varied manifestations. These will undergo peer review.  Preference will be given to less common entities where there may be diagnostic or management dilemmas.  It is recommended that authors contact the Associate Editor in advance to assure the topic has not been previously covered nor is in process.

Authors can review the literature on the topic, creating a table of important imaging findings across the literature for uncommon entities.  Alternatively, if recent prior good-quality reviews exist, those can be cited. Authors can also include new case series from their own institution in addition to reviewing the prior published literature.

Each figure legend should start with the patient age, clinical history/presentation, and diagnosis.  A composite figure of multiple parts that includes imaging and pathology for that patient should be created.  Arrows should indicate key imaging and pathology findings. The clinical BI-RADS assessment should be included in the legend whenever possible. The images should be shown chronologically, according to the clinical events. Information in the figure legends should not be repeated in the text.

• Please see a representative example of this manuscript type.

Training and professional development

These are focused summary articles on topics related to training and professional development, as it pertains to breast imaging. They may be original science or review articles. These articles may relate to aspects of teaching/learning, transitioning to practice, developing leadership skills, etc., and should support information with appropriate references whenever possible. Examples of articles in this section include how to teach US-guided biopsy, developing an academic career, using coaching for professional development, and a survey of fellowship directors regarding the virtual interview process.  Articles focused on personal experience are best suited for the SBI Newsletter. These manuscripts may be invited by the editor, but unsolicited submissions are equally welcome. All manuscripts will undergo peer review.

• Please see a representative example of this manuscript type.

Image spotlight

These are images that represent either an innovative imaging or interventional technique, or an exceptional example of an uncommon entity in breast imaging. This is not a forum for case reports. These do not undergo peer review and are accepted at the discretion of the editor.

• Please see a representative example of this manuscript type.

Unknown challenge

These are unknown cases with high-quality images and the following components: history, imaging findings, differential diagnosis, and discussion.  These cases should be challenging, but the reader should be able to make the most likely diagnosis based on the information provided.  These are not meant to be case reports.  No more than two authors are allowed.  These cases do not undergo peer review and are accepted at the discretion of the editor.

• Please see a representative example of this manuscript type.

Editorials

These are invited by the editor and reflect the opinions of the author. These will review the relevance and importance of an Original Research article relevant to other works. These will typically be written by a single author. Additional authors will be considered at the editor’s discretion. Editorials do not undergo peer review and are accepted at the discretion of the editor.

Statement/guidelines

Scientific statements or medical guidelines submissions will be considered as received from authoritative medical groups or societies. These must be relevant to breast imaging and include a comprehensive review of the literature supporting the position offered. These must be vetted and approved by the submitting society or medical group prior to submission.

Preparing your manuscript

General guidelines on preparing your manuscript for publication can be found on OUP’s Preparing and submitting your manuscript page. Specific instructions for JBI can be found below.

General formatting guidance

Please avoid jargon, such as “breast imagers,” using “breast imaging radiologists” or “breast radiologists” instead. Likewise, a more formal style is preferred to informal. As such, in general, avoid personal pronouns. For example, instead of “Next we excluded women under age 40 years” try “Women under age 40 years were excluded.”

BI-RADS can be used in the abstract. In the manuscript, please expand at first use as Breast Imaging Reporting and Data System (BI-RADS) and cite per the ACR recommendation. If different editions were used, then cite each separately. If citing only a portion of the lexicon (e.g. mammography, US, MRI or Quality), instructions for correct citation are also available at this website.

MLO and CC. At first use in the text, please spell out as mediolateral oblique (MLO) and craniocaudal (CC). In the figure legends or tables, just use MLO and CC. If MLO or CC are not included in the text of the paper, then MLO and CC should be spelled out in the first figure used.

For hormone receptor information, the following formats can be used:

Please specify equipment used if appropriate by stating the type of equipment followed by the manufacturer and their headquarters. For example, “US examinations were performed using L17-5 MHz transducers (Philips iU22, Amsterdam, Netherlands).”

Text abstracts

Text abstracts must be written in English.

Graphical abstracts

A graphical abstract is a single figure prepared by the authors that summarizes the key point(s) of an article and serves as a visual introduction to encourage interest in the content. When preparing your graphical abstract, keep in mind that they are ideally suited for promoting your article on social media, so text should be large enough to be read in that context and the image should be oriented in landscape format.

Please also consider the accessibility of your graphical abstract to all readers. See OUP's Guidelines for making figures accessible.

Graphical abstracts are peer reviewed and published as part of the article online and in the PDF. It also appears in the table of contents and some other journal pages including in search results.

Your graphical abstract should be submitted as a separate file, selecting the appropriate file type designation in the online submission system. The file should be named “graphical_abstract”. Please see OUP's guidance on appropriate file format and resolution for graphics.

Figures

Images should be of the highest resolution available for that modality. Generally 300 dpi is the minimum acceptable resolution for publication. Screen captures are rarely of sufficient resolution for publication. Please crop parts of the image that do not contribute to the message (e.g. black background on mammography, focal zones on US, excess field-of-view on MRI).

Upon acceptance for publication or acceptance with minor/major revision, please add embedded figure labels that are appropriate in size and location for publication. Text within figures is typically not edited during production. Ensure that a consistent, embedded typeface is used. Common typefaces such as Arial, Helvetica, Courier or Symbol are recommended to ensure clear reproduction and the retention of any special characters. Size of labels should be consistent throughout the figure. Similarly, please ensure that the size and thickness of arrows or other markers is sufficient for publication. Dashed and solid arrows are preferred over colored arrows when multiple arrows are needed. All findings should be marked by an arrow (or other object) and noted in the figure legend (arrow), even when the finding seems obvious

Example:

Figure accessibility and alt text

Incorporating alt text (alternative text) when submitting your paper helps to foster inclusivity and accessibility. Good alt text ensures that individuals with visual impairments or those using screen readers can comprehend the content and context of your figures. The aim of alt text is to provide concise and informative descriptions of your figure so that all readers have access to the same level of information and understanding, and that all can engage with and benefit from the visual elements integral to scholarly content. Including alt text demonstrates a commitment to accessibility and enhances the overall impact and reach of your work.  

Alt text is applicable to all images, figures, illustrations, and photographs. 

Alt text is only accessible via e-reader and so it won’t appear as part of the typeset article. 

Detailed guidance on how to draft and submit alt text. 

Pre-submission language editing

You may wish to use a language-editing service before submitting to ensure that editors and reviewers understand your manuscript. Our publisher, Oxford University Press, partners with Enago, a leading provider of author services. Through the OUP-Enago partner page, prospective authors are entitled to a discount for language editing, abstract and layperson summary writing, rejected manuscript editing, and creation of graphical abstracts, illustrations, and videos.

Enago is an independent service provider, which will handle all aspects of this service, including payment. As an author you are under no obligation to take up this offer. Language editing and other services from Enago are optional and do not guarantee that your manuscript will be accepted. Edited manuscripts will undergo the regular review process of the Journal. For more details and a list of additional resources, please see OUP’s page on language services.

Peer review process

The Journal operates double-anonymized peer review, meaning that the identity of the authors is hidden from reviewers, and the reviewers’ identities are hidden from the authors. The editors know the identity of both the reviewers and the authors.

During peer review, reviewers communicate directly with the editors but not the authors or other reviewers.

Once a submitted manuscript passes initial assessment by the Journal’s Editor-in-Chief, it will then be passed to a handling editor, who will oversee peer review and recommend a final decision. The Editor-in-Chief makes the final decision on the submitted manuscript. 

Editors and reviewers must not handle manuscripts if they have a conflict of interest with an author or the content. Editors make every effort to avoid potential conflicts of interest in the assignment of other editors and peer reviewers. For more information, please see the section on Disclosure of potential conflicts of interest. During the peer review phase, your manuscript is typically sent to 2 reviewers. 

You may suggest potential reviewers at submission. However, there is no guarantee the suggested reviewers will be selected by the Journal. Recommended reviewers should be experts in their field and able to provide an objective assessment of your manuscript without financial or interpersonal conflicts of interest with any authors. We encourage you to consider reviewers from a diverse range of backgrounds, including those from under-represented communities. 

Statistical methods should be rigorous, and reporting of statistical findings should be accurate and complete. Editors may request an expert statistical review of any submission containing statistical analysis. 

If your manuscript is accepted for publication, no information about the review process or editorial decision process is published, unless one of the authors has a role on the journal. See the Disclosure of potential conflicts of interest section for more information in that case.

For full details about the peer review process, see Fair editing and peer review. 

Screening for misconduct

Manuscripts will be screened using iThenticate to help detect publication misconduct including plagiarism and redundant publication.

The Journal uses ScholarOne's Unusual Activity Detection tool to build confidence in the identity of authors and reviewers.

Appeals and complaints

Authors may appeal an editorial decision. To do so, please contact the editorial office at jbreim.editorialoffice@jjeditorial.com, providing as much specific detail as possible about why the original decision should be reconsidered. Every appeal will receive a response within a reasonable timeframe. Please do not resubmit your manuscript in the interim.

To register a complaint regarding non-editorial decisions, the Journal’s policies and procedures, editors, or staff, please contact us. Complaints will be taken seriously and will be carried forward following COPE guidelines and processes and/or sanctions will be enacted if deemed appropriate.

Publication and research ethics

Authorship

Authorship is limited to those who have made a significant contribution to the design and execution of the work described. Any contributors whose participation does not meet the criteria for authorship should be acknowledged but not listed as an author. The Journal will contact all listed authors at the point of submission to confirm their role. For a detailed definition of authorship, please see the International Committee of Medical Journal Editors (ICMJE) definitions of authors and contributors.

The Journal does not allow ghost authorship, where an unnamed author prepares the article with no credit, or guest/gift authorship, where an author who made little or no contribution is listed as an author. The Journal follows Committee on Publication Ethics (COPE) guidance on ghost, guest, or gift authorship. For more information, please see the OUP Publication Ethics page.

Natural language processing tools driven by artificial intelligence (AI) do not qualify as authors, and the Journal will screen for them in author lists. The use of AI (for example, to help generate content or images, write code, process data, or for translation) should be disclosed both in cover letters to editors and in the Methods or Acknowledgements section of manuscripts. Please see the COPE position statement on Authorship and AI for more details.

After manuscript submission, no authorship changes (including the authorship list, author order, and who is designated as the corresponding author) should be made unless there is a substantive reason to do so. The editor and all co-authors must agree on the change(s), and neither the Journal nor the publisher mediates authorship disputes. If individuals cannot agree on the authorship of a submitted manuscript, contact the editorial office at jbreim.editorialoffice@jjeditorial.com. The dispute must be resolved among the individuals and their institution(s) before the manuscript can be accepted for publication. If an authorship dispute or change arises after a paper is accepted, contact OUP’s Author Support team. COPE provides guidance for authors on resolving authorship disputes.

After submission, changing who is designated as the corresponding author will be permitted only where there is a substantive reason to do so. For the avoidance of doubt, changing the corresponding author in order to access Read and Publish funding is not permissible. For more information on Read and Publish funding, see the Open access charges section.

ORCiD

Authors are encouraged to provide their ORCID iDs (Open Researcher and Contributor IDs) at submission and take advantage of the benefits of participating in ORCID. If you do not already have an ORCID iD, you can register for free via the ORCID website. 

As ORCID identifiers are collected, they are included in papers and displayed online, both in the HTML and PDF versions of the publication, in compliance with recommended practice issued by ORCID.

ORCID functionality online allows users to link to the ORCID website to view an author’s profile and list of publications. ORCID iDs are displayed on web pages and are sent downstream to third parties in data feeds, where supported.

If you have registered with ORCID, you can associate your ORCID iD with your submission system account by going to your account details, entering your ORCID iD, and validating your details. Learn more about ORCID and how to link it to your account.

Disclosure of potential conflicts of interest

Authors

The Journal requires all authors to disclose any potential conflict of interest at the point of submission. It is the responsibility of the corresponding author to ensure that conflicts of interest of all authors are declared to the Journal.

A conflict of interest exists when the position, activities, or relationships of an individual, whether direct or indirect, financial or non-financial, could influence or be seen to influence the opinions or activities of the individual. For more information, refer to OUP’s definition of conflict of interest.

The Journal follows the COPE guidance for any undisclosed conflict of interest that emerges during peer review, production, or after publication.

The corresponding author must submit a completed and signed International Committee of Medical Journal Editors (ICMJE) disclosure of potential conflicts of interest (COI) form for each author . A form must be submitted even if there are no interests to disclose, in which case the disclosure form and manuscript should state “none declared.” In addition, the manuscript must include a concise and accurate summary of any conflicts of interest declared in the ICMJE forms.

Reviewers

Individuals that have a conflict of interest relating to a submitted manuscript should recuse themselves and will not be assigned to oversee, handle, or peer review the manuscript.

If during peer review an editor, reviewer, or author becomes aware of a conflict of interest that was not previously known or disclosed they must inform the Editor-in-Chief immediately.

Editors

At initial submission, the corresponding author must declare if the Editor-in-Chief, an editor, or an Editorial Board Member of the Journal is an author of or contributor to the manuscript. Another editor without a conflict of interest will oversee the peer review and decision-making process. If accepted, a statement will be published in the paper describing how the manuscript was handled. The statement will read “[Author name] holds the position of [role] for JBI and has not peer reviewed or made any editorial decisions for this paper."

Previously published material

You should only submit your manuscript(s) to the Journal if:

• It is original work by you and your co-author(s).
• It is not under consideration, in peer review, or accepted for publication in any other publication.
• It has not been published in any other publication.
• It contains nothing abusive, defamatory, derogatory, obscene, fraudulent, or illegal.

The submitting author must disclose in their cover letter and provide copies of all related or similar preprints, dissertations, manuscripts, published papers, and reports by the same authors (i.e., those containing substantially similar content or using the same, similar, or a subset of data) that have been previously published or posted electronically or are under consideration elsewhere at the time of manuscript submission. You must also provide a concise explanation of how the submitted manuscript differs from these related manuscripts and papers. All related previously published papers should be cited as references and described in the submitted manuscript.

The Journal does not discourage you from presenting your findings at conferences or scientific meetings but recommends that you refrain from distributing complete copies of your manuscripts, which might later be published elsewhere without your knowledge.

For previously published materials including tables and figures, please see the Reusing copyrighted materials section.

Preprints

As an author, you retain the right to make an Author’s Original Version (preprint) available through various channels and this does not prevent submission to the Journal. If accepted, you are required to update the status of any preprint, including adding your published paper’s DOI. For full details on allowed channels and updating your preprint, please see our Author self-archiving policy.

Reusing copyrighted material

As an author, you must obtain permission for any material used within your manuscript for which you are not the rightsholder, including quotations, tables, figures, images, data, or software. In seeking permissions for published materials, first contact the publisher rather than the author. For unpublished materials, start by contacting the creator. Copies of each grant of permission should be provided to the editorial office of the Journal. The permissions agreement must include the following:

• Nonexclusive rights to reproduce the material in your paper in JBI
• Rights for use in print and electronic format at a minimum, and preferably for use in any form or medium
• Lifetime rights to use the material
• Worldwide English-language rights

If you have chosen to publish under an open access license but have not obtained open access re-use permissions for third-party material contained within the manuscript, this must be stated clearly by supplying a credit line alongside the material with the following information:

• Title of content
• Author, Original publication, year of original publication, by permission of [rightsholder]
• This image/content is not covered by the terms of the Creative Commons license of this publication. For permission to reuse, please contact the rights holder.

Our publisher, Oxford University Press, provides detailed Copyright and Permissions Guidelines, and a summary of the fundamental information.

Misconduct

Authors should observe high standards with respect to research integrity and publication ethics as set out by the Committee on Publication Ethics (COPE). Falsification or fabrication of data including inappropriate image manipulation, plagiarism, including duplicate publication of the author's own work without proper citation, and misappropriation of work are all unacceptable practices. Allegations of ethical misconduct, both directly and through social media, are treated seriously and will be investigated in accordance with the relevant COPE guidance.

If misconduct has been established beyond reasonable doubt, this may result in one or more of the following outcomes, among others:

• If a submitted manuscript is still under consideration, it may be rejected and returned to the author.
• If a paper has already been published online, depending on the nature and severity of the infraction, either a correction notice will be published and linked to the paper, or retraction of the paper will occur, following the COPE Retraction Guidelines.
• The relevant party’s institution(s) and/or other journals may be informed.

Manuscripts submitted to the Journal may be screened with plagiarism-detection software. Any manuscript may be screened, especially if there is reason to suppose that part or all the of the manuscript has been previously published.

COPE defines plagiarism as:

“when somebody presents the work of others (data, words or theories) as if they were their own and without proper acknowledgment.”

COPE defines redundant/overlapping publication as: 

“when a published work (or substantial sections from a published work) is/are published more than once (in the same or another language) without adequate acknowledgment of the source/cross-referencing/justification,
or
when the same (or substantially overlapping) data is presented in more than one publication without adequate cross-referencing/justification, particularly when this is done in such a way that reviewers/readers are unlikely to realise that most or all the findings have been published before.”

COPE defines citation manipulation as: 

“behaviours intended to inflate citation counts for personal gain, such as: excessive self-citation of an authors’ own work, excessive citation to the journal publishing the citing article, and excessive citation between journals in a coordinated manner.”

Data fabrication is defined as intentionally creating fake data or misrepresenting research results. An example includes making up data sets.

Data falsification is defined as manipulating research data with the purpose of intentionally giving a false representation. This can apply to images, research materials, equipment, or processes. Examples include cropping of gels/images to change context and omission of selected data.

If notified of a potential breach of research misconduct or publication ethics, the Journal editor and editorial office staff may inform OUP and/or the author’s institutional affiliation(s).

Ethical research

The Journal follows Committee on Publication Ethics (COPE) guidelines on ethical oversight. We take research integrity seriously, and all research published in the Journal must have been conducted in a fair and ethical manner. Wherever appropriate, the Journal requires that all research be done according to international and local guidelines.

Human participants

When reporting on human participants, you should indicate whether the procedures followed were in accordance with the ethical standards of the Helsinki Declaration, which were developed by the World Medical Association. For non-interventional studies, where ethical approval is not required or where a study has been granted an exemption by an ethics committee, this should be stated within the manuscript with a full explanation. Otherwise, manuscripts must include a statement in the Methods section that the research was performed after approval by a local ethics committee, institutional review board and/or local licensing committee, or that such approval was not required. The name of the authorizing body and any reference/permit numbers (where available) should also be stated there. Please be prepared to provide further information to the editorial office upon request.

Human participants must give written informed consent, or if they are minors or incapacitated, such consent must be obtained from their parents or guardians. Consent forms should cover not only study participation but also the publication of the data collected and deposition in databases and/or biobanks. Also, any patient or provider information should be anonymized to the extent possible; names and ID numbers should not be used in the text and must be removed from any images (X-rays, photographs, etc.). Please note blanking out an individual’s eyes in a photograph is not an effective way to conceal their identity. In studies where verbal, rather than written, informed consent was obtained, this must be explained and stated within the manuscript. If informed consent is not required or where a study has been granted an exemption, this must be included in the Methods section along with the name of the authorizing body. The Journal does not routinely collect consent forms, but authors should be prepared to provide written consent forms signed by the participants or other appropriate documentation to the editorial office upon request. For further guidance and examples, please refer to COPE’s guidance on consent.

Clinical trials

Clinical trials should be registered before enrollment of the first participant in accordance with the criteria outlined by the International Committee of Medical Journal Editors (ICMJE). When reporting primary or secondary analyses from a clinical trial, follow these criteria:

• Provide the trial registration number at the end of the Abstract.
• When the trial acronym is first used in the manuscript, provide the registration number and a link to the trial registration, which should be cited as a reference.
• If your data have been deposited in a public repository and/or are being used in a secondary analysis, please state at the end of the Abstract the unique, persistent data set identifier, and repository name and number.
• When submitting the manuscript, you must disclose any protocol alterations and all posting of results of the submitted work or closely related work in registries.
• In reporting randomized clinical trials, you must comply with published CONSORT guidelines.· Complete the recommended checklist and be prepared to provide it to the editorial office upon request.· Present the recommended trial flow diagram as a figure in the manuscript or as supplementary material.· If your manuscript reports on a randomized Phase II/III trial, you must provide a brief description of the statistical plan of the original study that includes the primary and secondary endpoints, power calculation, and sample size.

Where available, registration numbers should be provided not only for the trial you are reporting but also for any other trial mentioned in the manuscript. When the trial acronym is first used in the manuscript, provide the registration number and a link to the trial registration, which should be cited as a reference. 

Inclusive language and images

As defined by the Linguistic Society of America: 

“Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities”

We encourage you to consider using inclusive language and images when preparing your manuscript. For guidelines, please see the Linguistic Society of America guidelines
 

Accessibility

Written, visual, and audio content in your submission should be accessible to all. Please see the C4DISC guidelines for making text, images, charts, tables, and audio and video accessible.

Availability of data and materials

Where ethically feasible, the Journal strongly encourages authors to make all data and software code on which the conclusions of the paper rely available to readers. Whenever possible, data should be presented in the main manuscript or additional supporting files or deposited in a public repository. Visit OUP’s Research data page for information on general repositories for all data types, and resources for selecting repositories by subject area. When data and software underlying the research article are available in an online source, authors should include a full citation in their reference list. For details of the minimum information to be included in data and software citations see the OUP guidance on citing research data and software.

Choosing where to archive your data

Authors are highly encouraged to select a repository that issues DOIs as this helps to facilitate persistent linking to the dataset from the research article. You may refer to online resources such as FAIRsharing.org and re3data.org for lists of data repositories, including information on certification status and services offered.

We suggest you consider these options when choosing your repository:

Code Ocean (for data and code)
Dryad Digital Repository
Figshare
Harvard Dataverse
Open Science Framework
Zenodo
 

Digital preservation

Content published in the Journal will automatically be deposited into digital preservation services, including CLOCKSS, the Global LOCKSS Network, and Portico. This ensures the long-term preservation of your work. Through LOCKSS, participating institutions can sustain access to content if the Journal were to otherwise be unavailable, even for a short period of time. Should the Journal ever cease to publish, or content would otherwise become permanently unavailable, long-term access to the archives of CLOCKSS and Portico would be triggered. Until such a trigger event were to occur, this content is not available to the public through CLOCKSS and Portico.

Self-archiving

Self-archiving refers to posting a copy of your work on a publicly accessible website or repository. Under certain circumstances, you may self-archive versions of your work on your own webpages, on institutional webpages, and in other repositories. For information about the Journal's policy, and to learn which version(s) of your paper are acceptable for self-archiving, please see our Author self-archiving policy.

Publishing agreement and charges

Authors, please read each section on the publishing agreement and charges carefully.

If you have any questions relating to your publishing agreement or charges please contact OUP Support.

Publishing agreement

After your manuscript is accepted, you will be asked to sign a license to publish through our licencing and payment portal, SciPris. The Journal offers the option of publishing under either a non-open access (standard) license or an open access (Creative Commons) license. There is a charge to publish under an open access license, which allows your paper to be freely accessible to all readers immediately upon online publication. Editorial decisions occur prior to this step and are not influenced by payment or ability to pay. The standard license makes your paper available only to Journal subscribers and there is no license charge. This license grants OUP an exclusive license to publish and distribute the content. There is no transfer of ownership of the copyright. You, the author, retain copyright for the content.

Papers can be published under the following:

• CC-BY

Please see the OUP guidance on Licences, copyright, and re-use rights for more information regarding these publishing agreement options.

Complying with funder mandates

Please note that some funders require open access publication as a condition of funding. If you are unsure whether you are required to publish open access, please do clarify any such requirements with your funder or institution before selecting your license.

Further information on funder mandates and direct links to a range of funder policies.

Charges

Open access charges

Please see the details of open access licences and charges. If you select an open access license, you must pay the open access charge or request to use an institutional agreement to pay the open access charge through our licensing and payment portal, SciPris.

OUP has a growing number of open access agreements with institutions and consortia, which provide funding for open access publishing (also known as Read and Publish agreements). This means corresponding authors from participating institutions can publish open access, and the institution may pay the charge. Find out if your institution has an open access agreement.

To be eligible for one of OUP’s Read and Publish agreements, the corresponding author must provide their qualifying institution as their primary affiliation when they submit their manuscript. After submission, changing the corresponding author in order to access Read and Publish funding is not permissible.

The current charge for open access publication is $2,804. The charge is discounted by 20% if the corresponding author is a member of the Society of Breast Imaging.

Color charges

The Journal does not charge for color.

Page charges

The Journal does not have page charges.

Changes to published papers

The Journal will only make changes to published papers if the publication record is seriously affected by the academic accuracy of the published information. Changes to a published paper will be accompanied by a formal correction notice linking to and from the original paper.

As needed, we follow the COPE guidelines on retractions.

For more information and details of how to request changes, including for authors who wish to update their name and/or pronouns, please see OUP’s policy on changes to published papers.

Promoting your work

As the author, you are the best advocate for your work, and we encourage you to be involved in promoting your publication. Sharing your ideas and news about your publication with your colleagues and friends could take as little as 15 minutes and will make a real difference in raising the profile of your research.

You can promote your work by:

• Sharing your paper with colleagues and friends. If your paper is published open access, it will always be freely available to all readers, and you can share it without any limitations. Otherwise, use the toll-free link that is emailed to you after publication. It provides permanent, free access to your paper, even if your paper is updated.
• Signing up for an ORCID iD author identifier to distinguish yourself from any other researchers with the same name, create an online profile showcasing all your publications, and increase the visibility of your work.
• Using social media to promote your work. To learn more about self-promotion on social media, see our social media guide for authors.

Find out how Oxford University Press promotes your content. 

Contact us

For questions regarding submission and review, including appeals, you can reach the editorial office by email at jbreim.editorialoffice@jjeditorial.com.

After your paper has been sent to production, you can contact oupsupport@scipris.com for questions regarding publishing agreements and charges, the production process, or publication. Please see Changes to published papers if you need to request a substantive change to your published paper.